Ortin Global Limited (NSE:ORTINGLOBE)

Market Cap	140.75M -4.3%
Revenue (ttm)	1.12M -79.6%
Net Income	-8.95M
EPS	-1.10
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,578
Average Volume	8,817
Open	18.96
Previous Close	18.06
Day's Range	18.96 - 18.96
52-Week Range	9.64 - 18.96
Beta	0.29
RSI	82.11
Earnings Date	Feb 14, 2026

About Ortin Global

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulceran...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1986
• Employees: 3
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ORTINGLOBE

Financial Performance

In fiscal year 2025, Ortin Global's revenue was 3.43 million, a decrease of -84.61% compared to the previous year's 22.26 million. Losses were -8.46 million, -89.47% less than in 2024.